Friend murine leukemia virus
-
Subject Areas on Research
- A determination of the outer dimensions of oncornaviruses by several electron microscopic procedures.
- A human gamma globin gene variant binds SP1.
- A model for assembly of type-c oncornaviruses.
- A procedure for the preferential radioiodination of small amounts of protein in the presence of excess lipids.
- Absence of macrophage involvement in the passive serum therapy of Friend leukemia virus-induced disease.
- An analysis of type-C retrovirus polypeptides and their associations in the virion.
- An ultrastructural study of C-type virion assembly in mouse cells.
- Antigenic activity of human urothelial tissue.
- Antigenic relationships between murine, feline and primate RNA tumor viruses and membrane antigens of human leukemic cells.
- Characterization of the immune response to the major glycoprotein (gp 71) of Friend leukemia virus. I. Response in BALB/c mice.
- Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. II. Response in C57BL/6 mice.
- Characterization of the immune response to the major glycoprotein (gp71) of Friend leukemia virus. III. Influence on endogenous MuLV-mediated pathogenesis.
- Correlation of apparent molecular weight and antigenicity of viral proteins: an SDS-page separation followed by acrylamide-agarose electrophoresis and immunoprecipitation.
- Detection of the major glycoproteins of Friend leukemia virus (gp71) and the murine mammary tumor virus (gp52) on the surface of mouse cells.
- Immuno-prophylaxis and -therapy of C-type oncorna viral diseases in mice and cats.
- Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on surfaces of virus-producing murine and other mammalian species cell lines.
- Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on the surfaces of normal murine cells.
- Immunogenic determinants of a neuropathogenic murine leukemia virus.
- Immunologic control of the ascites form of murine adenocarcinoma 755. II. Tumor immunity associated with a Friend--Moloney--Ra,scher-type virus.
- Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
- Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
- In vivo antigenic modification of tumor cells. I. Introduction of murine leukemia virus antigens on non-virus-producing murine sarcomas.
- In vivo antigenic modification of tumor cells. II. Distribution of virus in sarcoma-bearing mice.
- Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin-mediated.
- Inducers of Friend leukaemic cell differentiation in vitro--effects of in vivo administration.
- Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus.
- Interspecies determinants of Friend leukemia virus antigens involved in cytolysis of virus-pfoducing cells.
- Interspecies reactivity of type C and D retrovirus p 15E and p 15C proteins.
- Ion fluxes and differentiation in transformed cell lines.
- Isolation of proteins by gel filtration in 6M guanidinium chloride: application to RNA tumor viruses.
- Localization of RNA tumor virus polypeptides. I. Isolation of further virus substructures.
- Loss of tumorigenicity following in vitro MuLV infection is associated with induction of peritoneal natural killer cell activity.
- Mammalian C-type oncornaviruses: relationships between viral structural and cell-surface antigens and their possible significance in immunological defense mechanisms.
- Neutralization of homologous and heterologous oncornaviruses by antisera against the p15(E) and gp71 polypeptides of Friend murine leukemia virus.
- Phospholipid membrane stabilization by dimethylsulfoxide and other inducers of Friend leukemic cell differentiation.
- Polypeptides of mammalian oncornaviruses. I. Isolation and serological analysis polypeptides from murine and feline C-type viruses.
- Polypeptides of mammalian oncornaviruses. II Characterization of murine leukemia virus polypeptide (p 15) bearing interspecies reactivity.
- Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody.
- Polypeptides of mammalian oncornaviruses. IV. Structural components of murine leukemia virus released as soluble antigens in cell culture.
- Polyploidy induction as a consequence of topoisomerase inhibition. A flow cytometric assessment.
- Properties of mouse leukemia viruses. II. Isolation of viral components.
- Properties of mouse leukemia viruses. XIII. Serum therapy of virus-induced murine leukemias.
- Properties of mouse leukemia viruses. XVI. Suppression of spontaneous fetal leukemias in AKR mice by treatment with broadly reacting antibody against the viral glycoprotein gp 71.
- Relationships between membrane antigens of human leukemic cells and oncogenic RNA virus structural components.
- Role of carbohydrate in biological functions of Friend murine leukemia virus gp71.
- Role of carbohydrate in determining the immunochemical properties of the major glycoprotein (gp71) of Friend murine leukemia virus.
- Specificity and distribution of the determinants of the major glycoprotein (gp71) of murine oncornaviruses as detected by an in vitro cytotoxicity assay.
- Structural components of rna tumor viruses.
- The effects of leukemosuppressive immunotherapy on bone marrow infectious cell centers in AKR mice.
- The effects of leukemosuppressive immunotherapy on thymic infectious cell centers in AKR mice.
- The role of bone marrow and thymic elements in the initiation and spread of virus production in the AKR thymus.